Nifty
Sensex
:
:
17196.70
57696.46
-204.95 (-1.18%)
-764.83 (-1.31%)

Pharmaceuticals & Drugs - Global

Rating :
57/99

BSE: 532331 | NSE: AJANTPHARM

2117.00
03-Dec-2021
  • Open
  • High
  • Low
  • Previous Close
  •  2092.15
  •  2137.95
  •  2055.10
  •  2117.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  80994
  •  1694.81
  •  2435.00
  •  1531.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 18,304.48
  • 25.92
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 18,096.56
  • 0.45%
  • 5.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.34%
  • 0.28%
  • 7.45%
  • FII
  • DII
  • Others
  • 8.72%
  • 11.94%
  • 1.27%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.61
  • 7.82
  • 12.03

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.43
  • 7.77
  • 12.01

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.81
  • 5.23
  • 19.11

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.98
  • 25.07
  • 25.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.62
  • 5.56
  • 4.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.91
  • 16.41
  • 15.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Net Sales
884.80
715.91
23.59%
747.99
668.20
11.94%
756.84
681.96
10.98%
748.74
651.21
14.98%
Expenses
621.98
441.66
40.83%
527.78
444.98
18.61%
497.43
530.62
-6.25%
507.06
465.24
8.99%
EBITDA
262.82
274.25
-4.17%
220.21
223.22
-1.35%
259.41
151.34
71.41%
241.68
185.97
29.96%
EBIDTM
29.70%
38.31%
29.44%
33.41%
34.28%
22.19%
32.28%
28.56%
Other Income
29.54
4.85
509.07%
32.63
13.12
148.70%
2.53
56.69
-95.54%
5.48
14.64
-62.57%
Interest
0.40
1.53
-73.86%
1.51
1.63
-7.36%
2.56
3.62
-29.28%
2.55
1.57
62.42%
Depreciation
31.54
28.33
11.33%
30.88
28.02
10.21%
30.60
26.04
17.51%
29.14
23.60
23.47%
PBT
260.42
249.24
4.49%
220.45
206.69
6.66%
228.78
175.86
30.09%
215.47
175.10
23.06%
Tax
64.48
79.02
-18.40%
46.70
58.93
-20.75%
69.52
46.70
48.87%
38.84
67.55
-42.50%
PAT
195.94
170.22
15.11%
173.75
147.76
17.59%
159.26
129.16
23.30%
176.63
107.55
64.23%
PATM
22.15%
23.78%
23.23%
22.11%
21.04%
18.94%
23.59%
16.52%
EPS
22.53
19.41
16.07%
19.98
16.85
18.58%
18.32
14.73
24.37%
20.31
12.26
65.66%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
3,138.37
2,889.69
2,587.87
2,055.37
2,125.76
1,983.26
1,733.98
1,473.56
1,208.34
930.84
677.39
Net Sales Growth
15.50%
11.66%
25.91%
-3.31%
7.19%
14.38%
17.67%
21.95%
29.81%
37.42%
 
Cost Of Goods Sold
740.48
514.99
537.75
295.72
317.35
322.58
317.33
290.33
283.98
250.11
187.93
Gross Profit
2,397.89
2,374.70
2,050.12
1,759.65
1,808.41
1,660.68
1,416.65
1,183.23
924.36
680.73
489.46
GP Margin
76.41%
82.18%
79.22%
85.61%
85.07%
83.73%
81.70%
80.30%
76.50%
73.13%
72.26%
Total Expenditure
2,154.25
1,891.13
1,904.55
1,488.94
1,467.37
1,296.38
1,146.92
968.33
839.59
706.35
545.36
Power & Fuel Cost
-
43.70
38.88
32.65
27.42
18.70
15.49
12.91
11.20
10.25
7.83
% Of Sales
-
1.51%
1.50%
1.59%
1.29%
0.94%
0.89%
0.88%
0.93%
1.10%
1.16%
Employee Cost
-
548.25
485.59
430.71
376.47
295.42
256.64
200.58
156.97
123.18
93.84
% Of Sales
-
18.97%
18.76%
20.96%
17.71%
14.90%
14.80%
13.61%
12.99%
13.23%
13.85%
Manufacturing Exp.
-
226.20
204.81
174.78
215.80
192.70
174.40
130.81
96.29
81.76
60.60
% Of Sales
-
7.83%
7.91%
8.50%
10.15%
9.72%
10.06%
8.88%
7.97%
8.78%
8.95%
General & Admin Exp.
-
131.92
159.49
149.90
131.92
92.02
66.24
50.99
47.40
37.02
33.88
% Of Sales
-
4.57%
6.16%
7.29%
6.21%
4.64%
3.82%
3.46%
3.92%
3.98%
5.00%
Selling & Distn. Exp.
-
374.73
413.70
320.99
306.30
270.92
245.92
233.96
201.57
169.99
131.40
% Of Sales
-
12.97%
15.99%
15.62%
14.41%
13.66%
14.18%
15.88%
16.68%
18.26%
19.40%
Miscellaneous Exp.
-
51.34
64.33
84.19
92.11
104.04
70.90
48.75
42.18
34.04
131.40
% Of Sales
-
1.78%
2.49%
4.10%
4.33%
5.25%
4.09%
3.31%
3.49%
3.66%
4.41%
EBITDA
984.12
998.56
683.32
566.43
658.39
686.88
587.06
505.23
368.75
224.49
132.03
EBITDA Margin
31.36%
34.56%
26.40%
27.56%
30.97%
34.63%
33.86%
34.29%
30.52%
24.12%
19.49%
Other Income
70.18
25.98
92.19
21.08
24.16
23.86
21.15
16.80
13.71
5.60
6.22
Interest
7.02
8.27
11.91
1.16
0.41
1.36
4.89
5.92
8.73
19.13
15.43
Depreciation
122.16
116.09
95.71
72.08
59.59
61.21
44.43
51.64
43.88
34.17
31.87
PBT
925.12
900.18
667.89
514.27
622.55
648.17
558.89
464.47
329.85
176.79
90.95
Tax
219.54
246.31
196.27
127.30
153.91
141.34
143.28
146.15
95.97
64.68
13.69
Tax Rate
23.73%
27.36%
29.56%
24.75%
24.72%
21.81%
25.64%
32.05%
29.10%
36.59%
15.05%
PAT
705.58
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
112.11
77.26
PAT before Minority Interest
705.58
653.87
467.70
386.97
468.64
506.83
415.61
309.86
233.88
112.11
77.26
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
22.48%
22.63%
18.07%
18.83%
22.05%
25.56%
23.97%
21.03%
19.36%
12.04%
11.41%
PAT Growth
27.20%
39.81%
20.86%
-17.43%
-7.54%
21.95%
34.13%
32.49%
108.62%
45.11%
 
EPS
81.57
75.59
54.07
44.74
54.18
58.59
48.05
35.82
27.04
12.96
8.93

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
2,995.63
2,598.87
2,245.21
2,041.37
1,567.69
1,190.86
841.09
593.31
393.43
298.03
Share Capital
17.39
17.54
17.54
17.69
17.69
17.69
17.68
17.67
11.80
11.80
Total Reserves
2,977.70
2,580.86
2,226.57
2,022.05
1,550.00
1,173.17
822.98
575.06
381.13
286.23
Non-Current Liabilities
274.55
227.61
162.23
38.56
8.90
28.63
55.67
80.62
102.46
100.59
Secured Loans
1.60
0.74
0.66
1.01
1.04
5.79
23.31
41.53
57.57
62.09
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
9.08
9.94
10.77
15.76
14.00
Long Term Provisions
208.12
155.01
134.15
13.16
4.88
2.59
4.76
2.83
2.98
4.91
Current Liabilities
838.82
745.53
498.35
346.05
246.66
259.89
249.59
275.42
222.34
250.19
Trade Payables
373.86
362.34
225.18
249.63
178.18
145.57
109.06
124.54
131.71
101.32
Other Current Liabilities
214.14
180.12
111.45
63.95
46.33
56.72
58.33
47.63
19.45
43.15
Short Term Borrowings
0.00
42.85
33.34
0.00
0.00
46.25
17.90
60.55
51.26
95.27
Short Term Provisions
250.82
160.22
128.38
32.47
22.15
11.35
64.30
42.70
19.92
10.45
Total Liabilities
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81
Net Block
1,541.11
1,472.14
1,168.35
1,052.66
589.17
450.74
288.09
279.39
272.56
246.12
Gross Block
2,140.78
1,976.15
1,578.96
1,417.23
894.94
715.73
549.85
492.00
438.49
378.01
Accumulated Depreciation
599.67
504.01
410.61
364.57
305.77
264.99
261.76
212.61
165.93
131.89
Non Current Assets
1,891.22
1,790.94
1,605.27
1,202.36
972.65
716.11
512.94
429.30
349.21
309.13
Capital Work in Progress
108.19
131.86
261.61
61.33
254.22
198.91
170.20
93.55
12.49
2.51
Non Current Investment
0.00
12.28
22.87
7.58
0.00
0.00
40.04
8.46
8.46
8.46
Long Term Loans & Adv.
230.74
164.20
148.36
76.79
41.88
21.29
9.34
39.15
48.61
50.75
Other Non Current Assets
11.18
10.46
4.08
4.00
2.34
4.28
5.27
8.75
7.09
1.29
Current Assets
2,217.78
1,781.07
1,300.52
1,223.62
850.60
763.27
633.41
520.05
369.02
339.68
Current Investments
175.67
67.14
64.74
182.38
181.56
76.78
19.46
55.00
0.00
0.00
Inventories
766.47
495.68
435.71
350.63
211.02
204.58
159.03
155.40
147.60
167.80
Sundry Debtors
738.43
775.30
459.48
459.79
323.15
372.35
258.76
202.22
150.47
141.00
Cash & Bank
209.61
205.25
100.51
93.09
69.95
43.37
136.76
60.39
46.23
11.48
Other Current Assets
327.60
69.02
96.63
114.62
64.92
66.19
59.40
47.04
24.72
19.40
Short Term Loans & Adv.
223.45
168.68
143.45
23.11
56.29
59.39
47.43
43.66
20.72
15.92
Net Current Assets
1,378.96
1,035.54
802.17
877.57
603.94
503.38
383.82
244.63
146.68
89.49
Total Assets
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
949.35
718.23
648.81

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
576.31
456.77
374.51
281.12
609.29
326.14
279.42
212.42
234.27
70.35
PBT
900.18
663.97
514.27
622.56
648.17
558.90
456.01
329.85
163.51
90.96
Adjustment
115.27
70.79
61.93
52.48
86.33
53.07
51.21
50.82
65.28
51.35
Changes in Working Capital
-208.75
-123.16
-83.46
-254.32
25.88
-124.34
-81.69
-74.52
38.60
-54.53
Cash after chg. in Working capital
806.70
611.60
492.74
420.72
760.38
487.63
425.53
306.15
267.39
87.78
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-230.39
-154.83
-118.23
-139.60
-151.09
-161.49
-146.11
-93.73
-33.12
-17.43
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-282.39
-224.40
-222.78
-256.11
-383.12
-209.07
-158.36
-187.80
-103.70
-53.07
Net Fixed Assets
-137.02
-255.91
-361.08
-327.21
-235.38
-197.00
-138.00
-120.60
-68.66
-46.30
Net Investments
-71.11
7.11
107.76
-1.82
-104.79
-17.41
2.22
-59.98
-1.81
0.00
Others
-74.26
24.40
30.54
72.92
-42.95
5.34
-22.58
-7.22
-33.23
-6.77
Cash from Financing Activity
-318.29
-128.63
-147.46
-0.20
-201.77
-117.32
-105.19
-20.13
-104.49
-12.84
Net Cash Inflow / Outflow
-24.37
103.74
4.27
24.81
24.40
-0.25
15.87
4.49
26.08
4.44
Opening Cash & Equivalents
202.36
95.16
90.64
65.83
41.42
41.67
38.62
34.13
8.05
3.61
Closing Cash & Equivalent
177.99
198.90
94.91
90.64
65.82
41.42
54.49
38.62
34.13
8.05

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
346.24
297.80
257.19
231.78
178.14
135.31
95.57
67.42
44.73
33.92
ROA
17.03%
14.44%
14.52%
22.06%
30.69%
31.66%
29.57%
28.05%
16.40%
13.20%
ROE
23.38%
19.32%
18.07%
25.98%
36.75%
40.92%
43.24%
47.47%
32.46%
29.34%
ROCE
32.20%
27.44%
23.84%
34.49%
45.74%
51.61%
56.43%
54.53%
38.62%
23.23%
Fixed Asset Turnover
1.40
1.46
1.37
1.84
2.49
2.76
2.85
2.61
2.29
1.98
Receivable days
95.60
87.08
81.62
67.06
63.41
65.84
56.64
52.93
56.78
65.22
Inventory Days
79.71
65.68
69.82
48.10
37.89
37.93
38.64
45.48
61.44
74.79
Payable days
67.55
59.55
63.24
57.26
50.30
41.91
46.38
59.31
61.76
59.93
Cash Conversion Cycle
107.77
93.21
88.21
57.90
51.01
61.86
48.91
39.10
56.46
80.09
Total Debt/Equity
0.00
0.02
0.02
0.00
0.00
0.07
0.09
0.22
0.32
0.67
Interest Cover
109.85
56.75
444.34
1519.41
477.60
115.29
78.03
38.78
10.24
6.89

News Update:


  • Ajanta Pharma - Quarterly Results
    29th Oct 2021, 14:29 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.